Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03881631 · ClinicalTrials.gov registry record · NA
Improving Well-Being for Older Adult Family Dementia Caregivers
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03881631: Completed NA study, sponsored by University of Rochester.
NCT03881631 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03881631, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.
Primary Outcome
Change in amount of antibody titers following influenza vaccination
Interventions
- BEHAVIORAL Mindfulness Based Stress Reduction Program
- BEHAVIORAL Living Well Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2016-07-18 |
| Est. Completion | 2023-05-03 |
| Phase | NA |
What the finished NCT03881631 record still lists
NCT03881631 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Based Stress Reduction Program is the first listed.
NCT03881631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03881631 about?
NCT03881631 is a clinical study titled "Improving Well-Being for Older Adult Family Dementia Caregivers". This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and we...
What is the current status of trial NCT03881631?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2016-07-18. Estimated completion is 2023-05-03.
What interventions are being tested in trial NCT03881631?
The interventions under investigation include: Mindfulness Based Stress Reduction Program (BEHAVIORAL), Living Well Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03881631?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03881631's enrollment target sits among peer trials
142 711th of 2000 higher than 1,289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI